Efficacy and Safety of VisuEvo® and Cationorm® for the Treatment of Evaporative and Non-Evaporative Dry Eye Disease: A Multicenter, Double-Blind, Cross-Over, Randomized Clinical Trial
Paolo Fogagnolo,1 Chiara Quisisana,1 Anna Caretti,2 Daniele Marchina,1 Michele Dei Cas,2 Ettore Melardi,1 Luca Rossetti1 1Eye Clinic ASST Santi Paolo Carlo, Department of Health Sciences, San Paolo Hospital, University of Milan, Milan, Italy; 2Department of Health Sciences, Laboratory of Biochemistr...
Guardado en:
Autores principales: | Fogagnolo P, Quisisana C, Caretti A, Marchina D, Dei Cas M, Melardi E, Rossetti L |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fd3a2a7c065b42b3b272235e8a1c1afd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Frequency and risk factors associated with dry eye in patients attending a tertiary care ophthalmology center in Mexico City
por: Martinez JD, et al.
Publicado: (2016) -
Comparison of the iLUX and the LipiFlow for the Treatment of Meibomian Gland Dysfunction and Symptoms: A Randomized Clinical Trial
por: Tauber J, et al.
Publicado: (2020) -
Influence of bacterial burden on meibomian gland dysfunction and ocular surface disease
por: Nattis A, et al.
Publicado: (2019) -
Ocular Surface Erosion after Suspected Exposure to Evaporated COVID-19 Vaccine
por: Somporn Chantra, et al.
Publicado: (2021) -
Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma
por: Walimbe T, et al.
Publicado: (2016)